AdamWolfeMDPhD

Radiation Oncology • Little Rock, AR

Gastrointestinal Cancer

Assistant Professor

Join to view full profile

Dr. Wolfe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wolfe's full profile

Already have an account?

Office
4301 W Markham St
# 783
Little Rock, AR 72205
Phone+1 501-686-8000

Education & Training

Ohio State University HospitalResidency, Radiation Oncology, 2017 - 2021
Wayne State University School of MedicineInternship, Transitional Year, 2016 - 2017
McGovern Medical School at UTHealthClass of 2016, MD, PhD
Texas Tech UniversityBS, Cell and Molecular Biology, Summa Cum Laude, 2005 - 2009

Certifications & Licensure

AR State Medical License 2021 - 2025
OH State Medical License 2017 - 2021
MI State Medical License 2016 - 2017
American Board of Radiology Radiation Oncology

Publications & Presentations

PubMed

Enhanced radiosensitivity of pancreatic cancer achieved through inhibition of Cyclin-dependent kinase 1.
Stetson Van Matre, Saaimatul Huq, Lokesh Akana, Daniel E Eldridge, Oscar Zuniga
Radiotherapy and Oncology. 2024-11-01
RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers.
Adam R Wolfe, Haihua Feng, Oscar Zuniga, Henrique Rodrigues, Daniel E Eldridge
Cancer Letters. 2024-06-01
Nutrient scavenging-fueled growth in pancreatic cancer depends on caveolae-mediated endocytosis under nutrient-deprived conditions.
Adam R Wolfe, Tiantian Cui, Sooin Baie, Sergio Corrales-Guerrero, Amy Webb
Science Advances. 2024-03-01

Press Mentions

American Cancer Society Funds UAMS Study To Understand Treatment Resistance in Pancreatic CancerJuly 13th, 2023